Staff Investigators

职员调查员

基本信息

批准号：
7944900
负责人：
ROBERT B. DIASIO
金额：
$ 3.58万
依托单位：
MAYO CLINIC ROCHESTER
依托单位国家：
美国
项目类别：
财政年份：
2009
资助国家：
美国
起止时间：
2009-04-17 至 2014-02-28
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/7944900
关键词：
6-Mercaptopurine Ablation American Angiogenesis Inhibitors Antibodies Appointment Aromatase Inhibitors Autologous Award B7-DC antigen Basic Science Biological Markers Blood donor Calendar Cancer Center Cancer Vaccines Carboplatin Cells Childhood Leukemia Clinic Clinical Clinical Investigator Clinical Pharmacology Clinical Research Clinical Trials Collaborations Comprehensive Cancer Center Cytotoxic T-Lymphocytes DNA Data Defect Dendritic Cells Dermatology Development Developmental Therapeutics Program Disease Doctor of Philosophy Enzymes Faculty Failure Funding General Hospitals Genetic Polymorphism Gold Grant Granulocyte-Macrophage Colony-Stimulating Factor Heat shock proteins Heating Hematologist Hematology Hormones Human Immune Immunity Immunization Immunologic Adjuvants Immunology Immunotherapeutic agent Immunotherapy In Situ Individual Inherited Injection of therapeutic agent Internal Medicine Internship and Residency Joints Kansas Laboratories Leadership Lesion Life Liver Lung Malignant Neoplasms Malignant neoplasm of pancreas Malignant neoplasm of prostate Massachusetts Mayo Clinic Cancer Center Medicine Mentors Metastatic Melanoma Molecular National Human Genome Research Institute National Institute of General Medical Sciences Nature North Central Cancer Treatment Group Oncologist Operative Surgical Procedures Paclitaxel Patients Peptide Vaccines Peptides Pharmaceutical Preparations Pharmacogenetics Pharmacogenomics Pharmacology Phase I Clinical Trials Phase III Clinical Trials Physicians Plasma Positioning Attribute Principal Investigator Publishing Radiofrequency Interstitial Ablation Randomized Reproduction spores Research Research Activity Research Personnel Resource Sharing Resources Role Sampling Scientific Advances and Accomplishments Scientist Series Societies Study Section Techniques Testing Therapeutic Therapeutic Agents Time Toxic effect Training Translating Translations Tumor Bank Tumor Immunity United States National Institutes of Health Universities Vaccine Clinical Trial Vaccines Variant Veins Wages Woman Work aerosolized anastrozole base bevacizumab cancer immunotherapy career crosslink drug metabolism editorial genome wide association study immunogenic in vivo malignant breast neoplasm melanoma member novel novel strategies novel therapeutics oncology outcome forecast peripheral blood preclinical study professor programs research clinical testing response thiopurine thiopurine methyltransferase trait tumor tumor immunology tumor progression working group

项目摘要

The Mayo Clinic Cancer Center (MCCC) is requesting partial salary support for two Staff Investigators. Neither of these two individuals has a leadership position within the Center, its programs, or its shared resources. Both of these Staff Investigators, however, are judged to be critical by the MCCC leadership to the operation of the Cancer Center for different reasons. One investigator is a physician-scientist with a major basic scientific role in the Center, providing expertise in pharmacogenomics that is a research direction of the Developmental Therapeutics Program and is important as a Staff Investigator determining newer approaches as to how to use therapeutic agents in various disease states; e.g., the Women's Cancer Program. The second investigator is a physician-scientist who has both a clinical role and a basic science role as a Staff Clinical Investigator in the Immunology and Immunotherapy Program. Most important, however, is that he has been a valuable translational scientist facilitating the studies of both basic scientists and clinicians.

梅奥诊所癌症中心（MCCC）要求为两名员工提供部分工资支持调查人员。这两个人都没有在中心的领导地位，程序或其共享资源。但是，这两个员工调查人员都被认为是由于不同的原因，MCCC领导层对癌症中心的运作至关重要。一研究者是一名医师科学家，在该中心中具有重要的基本科学作用，提供药物基因组学方面的专业知识是发育疗法的研究方向计划很重要，作为员工调查员，确定如何使用的新方法各种疾病状态的治疗剂；例如，女性癌症计划。第二个研究者是医师科学家，既有临床角色又是一员的基础科学角色免疫学和免疫疗法计划的临床研究者。但是，最重要的是他一直是一位宝贵的翻译科学家，促进了基础科学家和临床医生。